home / stock / acst / acst news


ACST News and Press, Acasti Pharma Inc. From 10/10/19

Stock Information

Company Name: Acasti Pharma Inc.
Stock Symbol: ACST
Market: NASDAQ
Website: acastipharma.com

Menu

ACST ACST Quote ACST Short ACST News ACST Articles ACST Message Board
Get ACST Alerts

News, Short Squeeze, Breakout and More Instantly...

ACST - Acasti Pharma And Amarin In Severe Hypertriglyceridemia

Branded Therapeutics: Vascepa Therapeutically, Vascepa launched in 2013 by Amarin ( AMRN ) is the current market leader over Lovaza launched in 2005 by GlaxoSmithKline ( GSK ). Epanova from AstraZeneca ( AZN ) was approved by the FDA in 2014. However, prior to its launch in 2014, Ama...

ACST - Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

LAVAL, Québec, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre ...

ACST - Acasti Pharma updates on Trilogy 1 and 2 trials; shares up 4% premarket

Acasti Pharma (NASDAQ: ACST ) reports additional milestones reached and provides a business update on its clinical trials. More news on: Acasti Pharma Inc., Healthcare stocks news, Stocks on the move, Read more ...

ACST - Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020

Nearly 80% of randomized patients have completed the studies Data clean-up for TRILOGY 1 is 90% completed Plan to present full data set including results for key secondary and exploratory endpoints of interest such as non-HDL-C, LDL-C, VLDL, HDL-C and HbA1c at key scientific meet...

ACST - Acasti Pharma (ACST) Investor Presentation - Slideshow

The following slide deck was published by Acasti Pharma Inc. in conjunction with this Read more ...

ACST - Acasti Pharma receives $750,000 funding to develop CaPre

Acasti Pharma (NASDAQ: ACST ) has been awarded up to $750,000 in non-dilutive and non-repayable funding, as well as technical and business advisory services, from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to apply towards R&D of Company&#...

ACST - Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity

LAVAL, Quebec, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”)  (NASDAQ: ACST – TSX-V: ACST) a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate ...

ACST - Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th

LAVAL, Québec, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre&#x...

ACST - DG, NTNX among premarket gainers

Appliance Recycling Centers of America (NASDAQ: ARCI ) +45% . on significant increase in orders in its recycling division. More news on: Appliance Recycling Centers of America, Inc., Nutanix, Inc., Safe-T Group Ltd, Stocks on the move, Read more ...

ACST - Citi cuts Solid Bio to Sell in premarket analyst action

Acasti Pharma (NASDAQ: ACST ) initiated with Buy rating at B. Riley FBR. More news on: Acasti Pharma Inc., Blueprint Medicines Corporation, Dova Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Previous 10 Next 10